TISON: a next-generation multi-scale modeling theatre for in silico systems oncology
Gondal, M. N.; Sultan, M. U.; Arif, A.; Rehman, A.; Awan, H. A.; Arshad, Z.; Ahmed, W.; Chaudhary, M. F.; Khan, S.; Tanveer, Z. B.; Butt, R. N.; Hussain, R.; Khawar, H.; Amina, B.; Akbar, R.; Abbas, F.; Jami, M. N.; Nasir, Z.; Shah, O. S.; Hameed, H.; Butt, M. F.; Mustafa, G.; Ahmad, M. M.; Ahmed, S.; Qazi, R.; Ahmed, F.; Ishaq, O.; Nabi, S. W.; Vanderbauwhede, W.; Wajid, B.; Shehwana, H.; Uddin, E.; Safdar, M.; Javed, I.; Tariq, M.; Faisal, A.; Chaudhary, S. U.
Show abstract
Multi-scale models integrating biomolecular data from genetic, transcriptional, and translational levels, coupled with extracellular microenvironments can assist in decoding the complex mechanisms underlying system-level diseases such as cancer. To investigate the emergent properties and clinical translation of such cancer models, we present Theatre for in silico Systems Oncology (TISON, https://tison.lums.edu.pk), a next-generation web-based multi-scale modeling and simulation platform for in silico systems oncology. TISON provides a "zero-code" environment for multi-scale model development by seamlessly coupling scale-specific information from biomolecular networks, microenvironments, cell decision circuits, in silico cell lines, and organoid geometries. To compute the temporal evolution of multi-scale models, a simulation engine and data analysis features are also provided. Furthermore, TISON integrates patient-specific gene expression data to evaluate patient-centric models towards personalized therapeutics. Several literature-based case studies have been developed to exemplify and validate TISONs modeling and analysis capabilities. TISON provides a cutting-edge multi-scale modeling pipeline for scale-specific as well as integrative systems oncology that can assist in drug target discovery, repositioning, and development of personalized therapeutics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.